A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
In plain words A study of D-mannose in female participants 55 to 85, run by University of Texas Southwestern Medical Center. It plans to enroll about 90 people at 1 US site.
Who it lists and where
Who the trial lists, as registered
Lists female participants 55 to 85. Conditions: Recurrent UTIs; Recurrent Urinary Tract Infections; Recurrent Urinary Tract Infections in Women; Recurrent Urinary Tract Infection; Cystitis Recurrent; Cystitis Chronic; UTI; UTI - Urinary Tract Infection; UTI - Lower Urinary Tract Infection.
- Female, post-menopausal, age ≥ 55 years old
- Diagnosis of recurrent UTI, defined as ≥ 3 symptomatic culture-proven UTI episodes in 12 months or ≥ 2 in 6 months.
- Currently free from a UTI determined based on absence of symptoms as determined by the UTI symptom assessment questionnaire79 and negative urine culture (<103 colony forming units per ml of urine).
- Able to attend all follow-up appointments for the study.
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
D-Mannose; Placebo
Registered summary
A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection) prevention in post-menopausal women.
Where, as registered
1 US site in 1 state.